Characterising health care-associated bloodstream infections in public hospitals in Queensland, 2008–2012
Authors: Naomi Runnegar, Damin Si and John Marquess
Published online: 19 September 2016
We appreciate the comments by Worth and colleagues on our article1 and agree that bloodstream infection (BSI) surveillance should occur with the goal of informing initiatives to prevent infection.
With regard to positive blood cultures caused by common skin commensals, in 2013, the surveillance definition from the Centre for Healthcare Related Infection Surveillance and Prevention (CHRISP) was updated in line with that of the United States National Healthcare Safety Network (NHSN). The updated CHRISP definition, which required two positive cultures for a common skin commensal if treatment was initiated, was developed to coincide with the newly deployed Multiprac health care-associated infection surveillance system in Queensland public hospitals. Our article acknowledged the impact of the use of the older definition.
Although the CHRISP surveillance definition of neutropenic sepsis is imperfect and includes reference to catheter tip cultures, it was implemented to create a distinction between BSI due to bacterial translocation across the gut in neutropenic patients and central line-associated BSI. The CHRISP definition was developed over a decade before the NHSN developed its classification of the mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI).2 The data collection period reported in our article predates the inclusion of the MBI-LCBI definition into the central line-associated BSI surveillance definition from the Australian Commission on Safety and Quality in Health Care.3 We do not advocate the comparison of specific rates of infection collected with different surveillance systems; however, our surveillance definitions are similar to those currently used in South Australia.4
We agree that standard infection control measures cannot prevent BSI caused by chemotherapy-induced neutropenia. Nevertheless, the data presented comparing neutropenic with non-neutropenic patients are of interest, because they demonstrate that the MBI-LCBI definition is potentially applicable in Queensland.
Quality improvement, including efforts to reduce health care-associated BSI rates, should be continuous. Nationally accepted definitions for surveillance3 should be applied where available. However, an inclusive approach to surveillance may facilitate a broader scope for BSI prevention. For example, efforts could be extended to prevent BSI caused by peripherally inserted venous catheters, indwelling urinary catheters and surgical site infections, which might not be measured by more targeted surveillance systems that exclusively use nationally accepted definitions.
Competing interests
References
- Si D, Runnegar N, Marquess J, et al. Characterising health care-associated bloodstream infections in public hospitals in Queensland, 2008–2012. Med J Aust 2016; 204: 276.
- See I, Iwamoto M, Allen-Bridson K, et al. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 2013; 34: 769-776.
- Australian Commission on Safety and Quality in Health Care. Implementation guide for surveillance of central line associated bloodstream infection. Canberra: Commonwealth of Australia, 2015. http://www.safetyandquality.gov.au/wp-content/uploads/2016/04/Implementation-Guide-for-Surveillance-of-Central-Line-Associated-Bloodstream-Infection-2016-Edition.pdf (accessed May 2016).
- Infection Control Service, South Australia Health. Bloodstream infection (BSI) surveillance. Adelaide: Department of Health, Government of SA, 2016. http://www.sahealth.sa.gov.au/wps/wcm/connect/3a836a00404920b397a7b7a05d853418/BSI-surveillance-definitions_V5.1-cdcb-ics-20160201.pdf?MOD=AJPERES&CACHEID=3a836a00404920b397a7b7a05d853418 (accessed May 2016).
Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study
Andrew Palmer, Matthew Carter, Jeremy Yeo, Cecilia Shim, Jason Connor, Jeremy Hayllar, Gerald Holtmann, Naomi Moy, Elliott G. Playford, Naomi Runnegar, Paul J. Clark
The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention
Cyra Patel, Alexis Pillsbury, Tran Nguyen, Xia Wang, Helen E. Quinn, Clayton K. Chiu, Allen C. Cheng, Katie L. Flanagan, Zhicheng Wang
Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia
Jessica Howell, Lauren Andersson, Miriam T. Levy, James O'Beirne, Leon Adams, Katharine Irvine, Avik Majumdar, Golo Ahlenstiel, Kathy Jackson, Krispin Hajkowicz, Joseph Doyle, Jane Davies, Sarah Cherian, Wayne Dimech, Alexander J. Thompson
Localised Herpes Simplex Following Midline Laparotomy
Jessica S. Bulluss, Paul Chee, Matthew J. Verheyden
West Nile virus Kunjin subtype in rural NSW
Emily Gibson, Megan Whitley, Peter Murray, Linda Hueston, Jane Bennett, Raguharan Kathiresu, David N Durrheim
Differentiated and simplified oral HIV pre‐exposure prophylaxis (PrEP) models hold the key to virtually eliminating HIV transmission in Australia by 2030
Tyson Arapali, Sarah Warzywoda, Anthony K J Smith, Curtis Chan, Timothy R Broady, Erin Sullivan, Catherine MacPhail, Mohamed A Hammoud, Alexander Dowell‐Day, Benjamin R Bavinton